GE HealthCare Technologies Inc. SEC filings GEHC

GE HealthCare Technologies Inc. has 445 filings in SEC EDGAR's recent list, going back to Jul 29, 2022. Its latest annual report, Form ARS, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.

GE HealthCare Technologies Inc. SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 4, 2026 —
10-Q Quarterly report Oct 28, 2026 Sep 30, 2026
8-K Current report
Results of operations, Officer or director change
Oct 28, 2026 Oct 22, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 22, 2026 Sep 22, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
3 Initial insider ownership Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 4, 2026 Sep 3, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Aug 18, 2026 Aug 15, 2026
8-K Current report
Officer or director change
Aug 18, 2026 Aug 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2026 —
8-K Current report
Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
8-K Current report
Results of operations, Officer or director change
Jul 23, 2026 Jul 21, 2026
SD Specialized disclosure (conflict minerals) May 29, 2026 —
4 Insider transaction May 26, 2026 May 22, 2026
4 Insider transaction May 19, 2026 May 15, 2026
4 Insider transaction May 19, 2026 May 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
8-K Current report
Shareholder vote results, Other events
May 11, 2026 May 7, 2026
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 6, 2026
3 Initial insider ownership May 5, 2026 Apr 29, 2026
4 Insider transaction May 1, 2026 May 1, 2026
4 Insider transaction Apr 30, 2026 Apr 30, 2026
4 Insider transaction Apr 30, 2026 Apr 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
10-Q Quarterly report Apr 29, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
ARS Annual report to shareholders Mar 19, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 19, 2026 —
DEF 14A Proxy statement Mar 19, 2026 May 7, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
3 Initial insider ownership Mar 17, 2026 Mar 13, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
8-K Current report
Material agreement, Agreement ended, New debt
Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
10-K Annual report Feb 4, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 4, 2026 Feb 4, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
8-K Current report
Material agreement, New debt, Other events
Dec 15, 2025 Dec 12, 2025
424B2 Prospectus Dec 2, 2025 —
8-K Current report
Other events
Dec 2, 2025 Dec 1, 2025
FWP Free writing prospectus Dec 1, 2025 —
424B2 Prospectus Dec 1, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
144 Notice of proposed sale Oct 27, 2025 —
144 Notice of proposed sale Sep 22, 2025 —
144 Notice of proposed sale Sep 12, 2025 —
4 Insider transaction Sep 12, 2025 Sep 11, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2025 —
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 30, 2025 Jul 30, 2025
8-K Current report
Officer or director change
Jul 24, 2025 Jul 23, 2025
8-K Current report
Other events
Jun 9, 2025 Jun 9, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 6, 2025 —
424B2 Prospectus Jun 5, 2025 —
8-K Current report
Other events
Jun 4, 2025 Jun 3, 2025
FWP Free writing prospectus Jun 3, 2025 —
4 Insider transaction Jun 3, 2025 Jun 1, 2025
424B2 Prospectus Jun 3, 2025 —
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
8-K Current report
Shareholder vote results
May 30, 2025 May 28, 2025
SD Specialized disclosure (conflict minerals) May 29, 2025 —
4 Insider transaction May 19, 2025 May 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2025 —
4/A Form 4/a May 7, 2025 Feb 2, 2025
3 Initial insider ownership May 1, 2025 May 1, 2025
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Results of operations, Other events
Apr 30, 2025 Apr 30, 2025
ARS Annual report to shareholders Apr 10, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 10, 2025 —
DEF 14A Proxy statement Apr 10, 2025 May 28, 2025
8-K Current report
Material agreement, Agreement ended, New debt
Mar 31, 2025 Mar 27, 2025
4 Insider transaction Mar 5, 2025 Mar 1, 2025
4 Insider transaction Mar 5, 2025 Mar 1, 2025
4 Insider transaction Mar 5, 2025 Mar 1, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
10-K Annual report Feb 13, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
4 Insider transaction Feb 10, 2025 Feb 6, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
4 Insider transaction Feb 4, 2025 Feb 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2025 —
8-K Current report
Material agreement, New debt
Dec 12, 2024 Dec 11, 2024
8-K Current report
Regulation FD disclosure
Nov 21, 2024 Nov 21, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
8-K Current report
Other events
Nov 8, 2024 Nov 7, 2024
424B3 Prospectus Nov 8, 2024 —
FWP Free writing prospectus Nov 7, 2024 —
4 Insider transaction Nov 6, 2024 Nov 5, 2024
144 Notice of proposed sale Nov 6, 2024 —
144 Notice of proposed sale Nov 5, 2024 —
4 Insider transaction Nov 5, 2024 Nov 5, 2024
4 Insider transaction Nov 5, 2024 Nov 1, 2024
8-K Current report
Regulation FD disclosure
Oct 30, 2024 Oct 30, 2024
10-Q Quarterly report Oct 30, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 30, 2024 Oct 30, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 22, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 22, 2024 —
8-K Current report
Other events
Sep 13, 2024 Sep 12, 2024
424B3 Prospectus Sep 13, 2024 —
FWP Free writing prospectus Sep 12, 2024 —
4 Insider transaction Sep 4, 2024 Sep 1, 2024
4 Insider transaction Sep 4, 2024 Sep 1, 2024
4 Insider transaction Sep 4, 2024 Sep 1, 2024
4 Insider transaction Sep 4, 2024 Sep 1, 2024
4 Insider transaction Sep 4, 2024 Sep 1, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844)
Listed as
GEHC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Chicago, IL
SEC filer status
Large accelerated filer
SEC CIK
1932393
Former names
GE Healthcare Holding LLC (until Dec 14, 2022)

Other X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.